BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25546391)

  • 1. The ubiquitin E3 ligase NOSIP modulates protein phosphatase 2A activity in craniofacial development.
    Hoffmeister M; Prelle C; Küchler P; Kovacevic I; Moser M; Müller-Esterl W; Oess S
    PLoS One; 2014; 9(12):e116150. PubMed ID: 25546391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cdh1 regulates craniofacial development via APC-dependent ubiquitination and activation of Goosecoid.
    Shao R; Liu J; Yan G; Zhang J; Han Y; Guo J; Xu Z; Yuan Z; Liu J; Malumbres M; Wan L; Wei W; Zou W
    Cell Res; 2016 Jun; 26(6):699-712. PubMed ID: 27126000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human prenatal craniofacial development related to brain development under normal and pathologic conditions.
    Kjaer I
    Acta Odontol Scand; 1995 Jun; 53(3):135-43. PubMed ID: 7572088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental neurogenesis in mouse and Xenopus is impaired in the absence of Nosip.
    Hoffmeister M; Krieg J; Ehrke A; Seigfried FA; Wischmann L; Dietmann P; Kühl SJ; Oess S
    Dev Biol; 2017 Sep; 429(1):200-212. PubMed ID: 28663132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MID1 E3 ligase catalyzes the polyubiquitination of Alpha4 (α4), a regulatory subunit of protein phosphatase 2A (PP2A): novel insights into MID1-mediated regulation of PP2A.
    Du H; Huang Y; Zaghlula M; Walters E; Cox TC; Massiah MA
    J Biol Chem; 2013 Jul; 288(29):21341-21350. PubMed ID: 23740247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definition of critical periods for Hedgehog pathway antagonist-induced holoprosencephaly, cleft lip, and cleft palate.
    Heyne GW; Melberg CG; Doroodchi P; Parins KF; Kietzman HW; Everson JL; Ansen-Wilson LJ; Lipinski RJ
    PLoS One; 2015; 10(3):e0120517. PubMed ID: 25793997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclopamine-induced holoprosencephaly and associated craniofacial malformations in the golden hamster: anatomic and molecular events.
    Coventry S; Kapur RP; Siebert JR
    Pediatr Dev Pathol; 1998; 1(1):29-41. PubMed ID: 10463269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UBE3A-mediated PTPA ubiquitination and degradation regulate PP2A activity and dendritic spine morphology.
    Wang J; Lou SS; Wang T; Wu RJ; Li G; Zhao M; Lu B; Li YY; Zhang J; Cheng X; Shen Y; Wang X; Zhu ZC; Li MJ; Takumi T; Yang H; Yu X; Liao L; Xiong ZQ
    Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12500-12505. PubMed ID: 31160454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of phenytoin on Satb2 and Hoxa2 gene expressions in mouse embryonic craniofacial tissue.
    Mao XY; Tang SJ
    Biochem Cell Biol; 2010 Aug; 88(4):731-5. PubMed ID: 20651846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microscopic study of holoprosencephalic facial anomalies in trisomy 13 fetuses.
    Sperber GH; Honoré LH; Machin GA
    Am J Med Genet; 1989 Apr; 32(4):443-51. PubMed ID: 2773983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The E3 ubiquitin ligase Wwp2 regulates craniofacial development through mono-ubiquitylation of Goosecoid.
    Zou W; Chen X; Shim JH; Huang Z; Brady N; Hu D; Drapp R; Sigrist K; Glimcher LH; Jones D
    Nat Cell Biol; 2011 Jan; 13(1):59-65. PubMed ID: 21170031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palate structure in human holoprosencephaly correlates with the facial malformation and demonstrates a new palatal developmental field.
    Kjaer I; Keeling J; Russell B; Daugaard-Jensen J; Fischer Hansen B
    Am J Med Genet; 1997 Dec; 73(4):387-92. PubMed ID: 9415463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of median craniofacial dysplasia.
    Allam KA; Wan DC; Kawamoto HK; Bradley JP; Sedano HO; Saied S
    Plast Reconstr Surg; 2011 Feb; 127(2):812-821. PubMed ID: 21285785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causal mechanisms of craniofacial deformity.
    Poswillo D
    Br Med Bull; 1975 May; 31(2):101-6. PubMed ID: 1164598
    [No Abstract]   [Full Text] [Related]  

  • 15. Animal models for human craniofacial malformations.
    Johnston MC; Bronsky PT
    J Craniofac Genet Dev Biol; 1991; 11(4):277-91. PubMed ID: 1812129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embryonic holoprosencephaly: pathology and phenotypic variability.
    Yamada S
    Congenit Anom (Kyoto); 2006 Dec; 46(4):164-71. PubMed ID: 17096815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Craniofacial anomalies: from development to molecular pathogenesis.
    Rice DP
    Curr Mol Med; 2005 Nov; 5(7):699-722. PubMed ID: 16305494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Holoprosencephaly and midline facial anomalies: redefining classification and management.
    Elias DL; Kawamoto HK; Wilson LF
    Plast Reconstr Surg; 1992 Dec; 90(6):951-8. PubMed ID: 1448530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleft lip and palate results from Hedgehog signaling antagonism in the mouse: Phenotypic characterization and clinical implications.
    Lipinski RJ; Song C; Sulik KK; Everson JL; Gipp JJ; Yan D; Bushman W; Rowland IJ
    Birth Defects Res A Clin Mol Teratol; 2010 Apr; 88(4):232-40. PubMed ID: 20213699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some abnormal patterns of development in the craniofacial region.
    Johnston MC; Sulik KK
    Birth Defects Orig Artic Ser; 1979; 15(8):23-42. PubMed ID: 518984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.